Steve Borthwick has handed a central contract to Henry Pollock, though Owen Farrell remains outside an enlarged list of 25 ...

Gain insights into CEVA, Inc.'s Q2 2025 earnings call, showcasing AI momentum, licensing growth, IoT leadership, and a positive outlook on revenue ...

Investors have the Monday blues after hearing Monday.com's forecast for 2025.

Analysts have given Stoke Therapeutics a total of 3 ratings, with the consensus rating being Buy. The average one-year price target is $29.0, indicating a potential 121.37% upside.

"Not even Nostradamus could have predicted the meteoric rise enjoyed in 2025 by Test-level rookie Henry Pollock." ...

Goodyear Tire GT incurred an adjusted loss per share of 17 cents in the second quarter of 2025, in contrast to the Zacks ...

The well-known growth stocks and most AI stocks have delivered eye-watering gains in the past two years. However, putting all ...

The stock has declined 28% in 2025, a steeper fall than the 13.5% drop in the broader Zacks Computer and Technology sector.

Theo Dan is the only player out of the 17-strong group named last October to miss out, with this year's group including Henry Pollock.

GAAP revenue for Q2 2025 was $161.1 million, falling short of analyst estimates of $164.5 million. Adjusted diluted EPS (non-GAAP) for Q2 2025 was $0.51, slightly above the consensus estimate of $0.50 ...

England Men’s head coach Steve Borthwick has announced the 25 players awarded with enhanced Elite Player Squad (EPS) contracts for the 2025/26 season.

Dividend investors are always on the lookout for stocks that will increase their passive income. While several companies have ...